EA200100269A1 - Иммуногенные липосомные композиции - Google Patents

Иммуногенные липосомные композиции

Info

Publication number
EA200100269A1
EA200100269A1 EA200100269A EA200100269A EA200100269A1 EA 200100269 A1 EA200100269 A1 EA 200100269A1 EA 200100269 A EA200100269 A EA 200100269A EA 200100269 A EA200100269 A EA 200100269A EA 200100269 A1 EA200100269 A1 EA 200100269A1
Authority
EA
Eurasian Patent Office
Prior art keywords
immunogenic
liposomic
compositions
liposomic compositions
antigenic
Prior art date
Application number
EA200100269A
Other languages
English (en)
Other versions
EA004797B1 (ru
Inventor
Гэрри Фудзии
Доналд В. Креймер
Уильям А. Эрнст
Джилл Адлер-Мур
Л. Джинн Перри
Original Assignee
Молекьюлар Экспресс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Молекьюлар Экспресс, Инк. filed Critical Молекьюлар Экспресс, Инк.
Publication of EA200100269A1 publication Critical patent/EA200100269A1/ru
Publication of EA004797B1 publication Critical patent/EA004797B1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Abstract

Данное изобретение относится к иммуногенной липосомной композиции, включающей пузырекобразующие липиды и антигенную конструкцию, включающую одну или несколько антигенных детерминант и гидрофобную область.Отчет о международном поиске был опубликован 2000.11.23.
EA200100269A 1998-09-22 1999-09-22 Иммуногенные липосомные композиции EA004797B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10135198P 1998-09-22 1998-09-22
US40072399A 1999-09-21 1999-09-21
PCT/US1999/020880 WO2000016746A2 (en) 1998-09-22 1999-09-22 Immunogenic liposome compositions

Publications (2)

Publication Number Publication Date
EA200100269A1 true EA200100269A1 (ru) 2001-12-24
EA004797B1 EA004797B1 (ru) 2004-08-26

Family

ID=26798150

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200100269A EA004797B1 (ru) 1998-09-22 1999-09-22 Иммуногенные липосомные композиции

Country Status (31)

Country Link
EP (1) EP1115382B1 (ru)
JP (1) JP2002526436A (ru)
KR (1) KR100592825B1 (ru)
CN (1) CN1555254A (ru)
AP (1) AP2010A (ru)
AT (1) ATE468108T1 (ru)
AU (1) AU766772B2 (ru)
BG (1) BG65675B1 (ru)
BR (1) BR9914004A (ru)
CA (1) CA2344173C (ru)
CY (1) CY1110718T1 (ru)
CZ (1) CZ20011013A3 (ru)
DE (1) DE69942393D1 (ru)
DK (1) DK1115382T3 (ru)
EA (1) EA004797B1 (ru)
EE (1) EE200100168A (ru)
ES (1) ES2345695T3 (ru)
GE (1) GEP20053444B (ru)
HK (1) HK1039064A1 (ru)
HU (1) HUP0105391A3 (ru)
ID (1) ID29082A (ru)
IL (2) IL141675A0 (ru)
MX (1) MXPA01002973A (ru)
NO (1) NO330685B1 (ru)
NZ (2) NZ510442A (ru)
OA (1) OA11657A (ru)
PL (1) PL206260B1 (ru)
SK (1) SK287670B6 (ru)
UA (1) UA75327C2 (ru)
WO (1) WO2000016746A2 (ru)
ZA (1) ZA200101829B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1868651A4 (en) * 2005-04-12 2010-10-06 Univ Duke METHOD FOR INDUCING ANTIBODIES THAT NEUTRALIZE THE HUMAN IMMUNODEFICIENCY VIRUS
CN102448488B (zh) 2009-06-04 2014-10-15 独立行政法人产业技术综合研究所 支原体感染症用疫苗
US20140287022A1 (en) * 2011-04-26 2014-09-25 Molecular Express, Inc. Liposomal formulations
US10076567B2 (en) 2013-09-27 2018-09-18 Duke University MPER-liposome conjugates and uses thereof
IL302880A (en) * 2017-04-04 2023-07-01 Avidea Tech Inc Peptide-based ingredients, production methods, and their uses for inducing an immune response
KR20240033309A (ko) * 2022-09-05 2024-03-12 주식회사 차백신연구소 에멀전 제형의 면역증강제 조성물 및 이의 제조 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8405493D0 (sv) * 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
SE462375B (sv) * 1985-10-15 1990-06-18 Morgaardshammar Ab Centro Traadblock
ES2032776T3 (es) * 1986-05-20 1993-03-01 Wako Pure Chemical Industries, Ltd. Nuevos liposomas funcionalizados y un procedimiento para su produccion.
FR2754543B1 (fr) * 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires

Also Published As

Publication number Publication date
BG65675B1 (bg) 2009-06-30
EA004797B1 (ru) 2004-08-26
JP2002526436A (ja) 2002-08-20
CY1110718T1 (el) 2015-06-10
EE200100168A (et) 2002-06-17
SK3222001A3 (en) 2001-09-11
WO2000016746A8 (en) 2000-08-10
ZA200101829B (en) 2002-06-05
BG105372A (en) 2001-10-31
ID29082A (id) 2001-07-26
NZ528055A (en) 2005-01-28
UA75327C2 (en) 2006-04-17
AU766772B2 (en) 2003-10-23
KR20010075261A (ko) 2001-08-09
EP1115382A2 (en) 2001-07-18
HK1039064A1 (en) 2002-04-12
IL141675A0 (en) 2002-03-10
HUP0105391A2 (hu) 2002-05-29
BR9914004A (pt) 2001-07-24
NO20011406D0 (no) 2001-03-20
OA11657A (en) 2004-12-08
NO20011406L (no) 2001-04-24
EP1115382B1 (en) 2010-05-19
SK287670B6 (sk) 2011-05-06
DE69942393D1 (de) 2010-07-01
WO2000016746A3 (en) 2000-11-23
WO2000016746A2 (en) 2000-03-30
ES2345695T3 (es) 2010-09-29
GEP20053444B (en) 2005-02-25
MXPA01002973A (es) 2003-03-27
PL206260B1 (pl) 2010-07-30
NZ510442A (en) 2003-10-31
AP2001002096A0 (en) 2001-03-31
HUP0105391A3 (en) 2006-02-28
WO2000016746A9 (en) 2000-09-21
IL141675A (en) 2007-06-17
KR100592825B1 (ko) 2006-06-23
ATE468108T1 (de) 2010-06-15
NO330685B1 (no) 2011-06-06
CA2344173C (en) 2010-02-23
AP2010A (en) 2009-06-29
CN1555254A (zh) 2004-12-15
PL348604A1 (en) 2002-06-03
DK1115382T3 (da) 2010-09-06
CZ20011013A3 (cs) 2002-03-13
AU6035199A (en) 2000-04-10
CA2344173A1 (en) 2000-03-30

Similar Documents

Publication Publication Date Title
EA200400067A1 (ru) Конъюгаты гксф
FR2810033B1 (fr) Nouveaux composes de la famille des n-acylamino-amides, compositions les comprenant, et utilisations
DE69419519T2 (de) Riechstoffe formulierungen
EA200100713A1 (ru) Препаративная форма галантамина с регулируемым выделением
ATE367845T1 (de) Riechstoffzusammensetzungen
PT758248E (pt) Formulacoes para o factor ix
EA199900598A1 (ru) Производные 1-арил- и пиридилпиразола с пестицидными свойствами
EA199901013A1 (ru) Гели пролонгированного действия
TR28023A (tr) Yüzeyaktif iyon cifti floresanli beyazlatici terkipleri.
DK1100789T3 (da) Substituerede benzoylcyclohexandioner
ATE321534T1 (de) Verbesserte liposomale formulierung
WO2001076369A3 (de) Wirkstoffkombinationen mit insektiziden und akariziden eigenschaften
CY1110718T1 (el) Ανοσογονες λιποσωμικες συνθεσεις
BR0110577A (pt) Decorina transgenicamente produzida
DE69736123D1 (de) Verbesserte brennstoffestabilität aufweisende brennstoffezusammensetzungen
IT1231013B (it) Mono (2 ammonio 2 idrossimetil 1,3 propandiolo)(2r,cis) 1,2 epossipropil fosfonato avente migliorate caratteristiche di stabilita' e lavorabilita'.
EA199900235A1 (ru) Аморфные бензотиофены, способы получения и способы применения
ATE120718T1 (de) Herstellung von peroxidzusammensetzungen.
DE59709372D1 (de) Riechstoffkompositionen enthaltend substituierte 2-Acetylbenzofurane
DE69931186D1 (de) Herstellung von wasserlöslichen sulfonierten organophosphor-verbindungen
EA200200073A1 (ru) Многодозовые эритропоэтиновые составы
DE60117465D1 (de) Lipide mit aminoxygruppe
FI915801A0 (fi) Komposition och foerfarande foer att foerhindra fluoros.
EE9900199A (et) Putukatõrje mikroemulsioonkompositsioonid
DE69903914D1 (de) Herstellung von 3-buten-1-ol aus 3,4-epoxy-1-buten

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU